Eric Lefkofsky, Tempus CEO, was recently featured in Bloomberg TV interview on data-driven medicine. The following is a recap of what he had to say.
Mining medical records
Technology is being leveraged in the healthcare sector to generate medical data for individual patients. Technology simplifies how patient records is stored as well as retrieved. Data storage in the healthcare sector has been a challenge but data-driven medicine has enabled platforms to provide the information just the way large tech companies stores their employees data. For example, it would be difficult to capture all information of sequencing cancer patients. Information integrity and accuracy in the healthcare sector is critical. Otherwise, medical practitioners may use inaccurate information to inform treatments. With data-driven medicine, patient information is available and accessible easily remotely.
How data-driven medicine affect healthcare costs
According to Eric Lefkofsky, with the increase in efficiency in the provision of medical care, medical practitioners can access information readily and speed up treatment. Ultimately, the benefits of data-driven medicine will out way costs. At the long-run, the quality of health care service delivery will increase and healthcare costs will reduce.
Any ethical issues?
One emerging ethical concern arising from data-driven medicine is the misuse of information made readily available. Eric Lefkofsky clarified that no industry that don’t experience security threats. Security protocols and programs can be designed to counter the threats.
About Eric Lefkofsky
Mr. Lefkofsky is the Co-Founder and CEO of Tempus, a leading company that provides technology enabled precision medicine solutions. He is also the co-founder of Lightbank, a venture fund investing in breakthrough technologies. He is also the co-founding Chairman of Mediaocean, Groupon, InnerWorkings, Echo Global Logistics and Uptake Technologies. The tech entrepreneur founded Lefkofsky Family Foundation for private charity in 2006. The graduate from the University of Michigan is also an adjunct professor at the University of Chicago.